Ross Abrams to Carcinoma, Small Cell
This is a "connection" page, showing publications Ross Abrams has written about Carcinoma, Small Cell.
Connection Strength
0.330
-
Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol. 1986 Oct; 4(10):1443-54.
Score: 0.073
-
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. J Clin Oncol. 2005 Aug 01; 23(22):4991-8.
Score: 0.066
-
The hematopoietic toxicity of regional radiation therapy. Correlations for combined modality therapy with systemic chemotherapy. Cancer. 1985 Apr 01; 55(7):1429-35.
Score: 0.065
-
Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol. 2003 Dec 15; 21(24):4553-9.
Score: 0.059
-
Amplification of circulating granulocyte-monocyte stem cell numbers following chemotherapy in patients with extensive small cell carcinoma of the lung. Cancer Res. 1981 Jan; 41(1):35-41.
Score: 0.049
-
Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group. Cancer Treat Rep. 1986 Oct; 70(10):1219-20.
Score: 0.018